What is the current Novo Nordisk A/S market capitalization?
The current market capitalization of Novo Nordisk A/S is 3.49 T DKK.
Novo Nordisk A/S Market capitalization 2024
Novo Nordisk A/S Market capitalization
3.49 T DKK
Ticker
NOVO B.CO
ISIN
DK0060534915
WKN
A1XA8R
In 2024, Novo Nordisk A/S's market cap stood at 3.49 T DKK, a 8.89% increase from the 3.21 T DKK market cap in the previous year.
The Novo Nordisk A/S Market capitalization history
| YEAR | Market Capitalization (undefined DKK) |
|---|---|
| 2023 | 2.63 |
| 2022 | 1.76 |
| 2021 | 1.29 |
| 2020 | 0.99 |
| 2019 | 0.81 |
| 2018 | 0.74 |
| 2017 | 0.7 |
| 2016 | 0.82 |
| 2015 | 0.93 |
| 2014 | 0.66 |
| 2013 | 0.52 |
| 2012 | 0.47 |
| 2011 | 0.35 |
| 2010 | 0.28 |
| 2009 | 0.18 |
| 2008 | 0.19 |
| 2007 | 0.18 |
| 2006 | 0.13 |
| 2005 | 0.1 |
| 2004 | 0.1 |
Novo Nordisk A/S Aktienanalyse
What does Novo Nordisk A/S do?
Novo Nordisk A/S is a Danish company specializing in the production of insulin and other diabetes medications. It was founded in 1923 and has its headquarters in Bagsværd, Denmark. Novo Nordisk is the world's largest manufacturer of insulin and one of the key players in the field of diabetes treatment. Novo Nordisk A/S ist eines der beliebtesten Unternehmen auf Eulerpool.com.Market capitalization Details
Exploring Novo Nordisk A/S's Market Capitalization
Novo Nordisk A/S's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.
Year-to-Year Comparison
A yearly comparison of Novo Nordisk A/S's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.
Impact on Investments
Novo Nordisk A/S's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.
Interpreting Market Capitalization Fluctuations
Variations in Novo Nordisk A/S’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.
Frequently Asked Questions about Novo Nordisk A/S stock
What is market capitalization?
The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Novo Nordisk A/S.
How has the market capitalization of Novo Nordisk A/S developed in recent years?
The market capitalization of Novo Nordisk A/S has increased/decreased by 8.89% compared to the previous year.
What does market capitalization mean for investors?
The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.
Why is market capitalization an important indicator for investors?
The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.
Why does the market capitalization fluctuate?
The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.
What role does market capitalization play in the valuation of Novo Nordisk A/S?
In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.
Does the market capitalization influence the performance of Novo Nordisk A/S?
There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
Does the market capitalization of Novo Nordisk A/S have an influence on indices?
Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).
How much dividend does Novo Nordisk A/S pay?
Over the past 12 months, Novo Nordisk A/S paid a dividend of 14.15 DKK . This corresponds to a dividend yield of about 1.82 %. For the coming 12 months, Novo Nordisk A/S is expected to pay a dividend of 14.94 DKK.
What is the dividend yield of Novo Nordisk A/S?
The current dividend yield of Novo Nordisk A/S is 1.82 %.
When does Novo Nordisk A/S pay dividends?
Novo Nordisk A/S pays a quarterly dividend. This is distributed in the months of September, April, September, September.
How secure is the dividend of Novo Nordisk A/S?
Novo Nordisk A/S paid dividends every year for the past 26 years.
What is the dividend of Novo Nordisk A/S?
For the upcoming 12 months, dividends amounting to 14.94 DKK are expected. This corresponds to a dividend yield of 1.92 %.
In which sector is Novo Nordisk A/S located?
Novo Nordisk A/S is assigned to the 'Health' sector.
Wann musste ich die Aktien von Novo Nordisk A/S kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Novo Nordisk A/S from 8/19/2024 amounting to 0.51 DKK, you needed to have the stock in your portfolio before the ex-date on 8/16/2024.
When did Novo Nordisk A/S pay the last dividend?
The last dividend was paid out on 8/19/2024.
What was the dividend of Novo Nordisk A/S in the year 2023?
In the year 2023, Novo Nordisk A/S distributed 11.15 DKK as dividends.
In which currency does Novo Nordisk A/S pay out the dividend?
The dividends of Novo Nordisk A/S are distributed in DKK.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Novo Nordisk A/S stock can be added to a savings plan with the following providers: Trade Republic, ING, Scalable Capital and Consorsbank
Andere Kennzahlen von Novo Nordisk A/S
Our stock analysis for Novo Nordisk A/S Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Novo Nordisk A/S Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Novo Nordisk A/S Revenue
- Novo Nordisk A/S Net Income
- Novo Nordisk A/S P/E
- Novo Nordisk A/S P/S
- Novo Nordisk A/S EBIT
- Novo Nordisk A/S Dividend
- Novo Nordisk A/S Stocks
- Novo Nordisk A/S Market capitalization
- Novo Nordisk A/S Debt
- Novo Nordisk A/S Liabilities
- Novo Nordisk A/S Equity
- Novo Nordisk A/S AAQS
- Novo Nordisk A/S Employees
- Novo Nordisk A/S ROE
- Novo Nordisk A/S ROA
- Novo Nordisk A/S ROCE
